⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15193376 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL2186118 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL27159005 | 0.96 | — | — | |
| SCHEMBL7249921 | 0.96 | — | — | |
| Nitric Oxide SCHEMBL7252419 | 0.90 | CHRNB2 (0.46) | — | |
| SCHEMBL27605 | 0.86 | — | — | |
| SCHEMBL4544653 | 0.86 | — | — | |
| SCHEMBL14660960 | 0.86 | CHRNB2 (0.42) | — | |
| SCHEMBL8657415 | 0.84 | CCR5 (0.43) | — | |
| SCHEMBL2388239 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070278-A | Bifunctional protein degradation agent containing aryl substituted heteroaryl and application thereof | 标新生物医药科技(上海)有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4695256-A2 | ERBB2 INHIBITORS | Cogent Biosciences, Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| US-12479827-B2 | Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2025-11-25 | — | — | US | claimed |
| EP-4648763-A2 | COMPOUNDS FOR FGFRS INHIBITORS | Cogent Biosciences, Inc. (US) | 2025-11-19 | — | — | EP | claimed |
| CN-120202200-A | Oxo-isoindolinyl substituted tetrahydropyrimidinedione-based compounds and applications thereof | 标新生物医药科技(上海)有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119874616-B | Organic intermediate and preparation method and application thereof | 四川美域高生物医药科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| EP-4547666-A1 | METHODS FOR TREATMENT OF CANCER | Frontier Medicines Corporation (US) | 2025-05-07 | — | — | EP | claimed |
| CN-119874616-A | Novel organic intermediate and preparation method and application thereof | 四川美域高生物医药科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| US-20250129078-A1 | ERBB2 INHIBITORS | COGENT BIOSCIENCES, INC. | 2025-04-24 | — | — | US | claimed |
| CN-119768392-A | Aryl or heteroaryl substituted glutarimide derivatives and uses thereof | 标新生物医药科技(上海)有限公司 | 2025-04-04 | — | — | CN | claimed |
| US-6727247-B2 | ADENOSINE RECEPTOR LIGANDS IN A METHOD OF TREATMENT, CONTROL, OR PREVENTION OF CENTRAL NERVOUS SYSTEM DISORDERS | HOFFMAN-LA ROCHE INC. | 2004-04-27 | — | — | US | claimed |
| WO-2004000324-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES RELATED TO NEUROTROPHINES | MIMETECH S.R.L. (IT) | 2003-12-31 | — | — | WO | claimed |
| WO-2003087304-A2 | TRI-SUBSTITUTED HETEROARYLS AND METHODS OF MAKING AND USING THE SAME | BIOGEN, INC. (US) | 2003-10-23 | — | — | WO | claimed |
| US-20030149036-A1 | Substituted benzothiazole amide derivatives | HOFFMAN-LA ROCHE INC. | 2003-08-07 | — | — | US | claimed |
| WO-2003049741-A1 | UREAS OF 2-AMINOBENZOTHIAZOLES AS ADENOSINE MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2003-06-19 | — | — | WO | claimed |
| US-5707985-A | Naphthyl-, quinolyl- and isoquinolyl- sulfonamide derivatives as cell adhesion modulators | TANABE SEIYAKU CO. LTD. (JP) | 1998-01-13 | — | — | US | claimed |
| EP-0345627-B1 | 9-R-azacyclic erythromycin antibiotics | ABBOTT LAB (US) | 1997-04-16 | — | — | EP | claimed |
| US-5185320-A | Antibiotics | GRUPPO LEPETIT S.P.A. (IT) | 1993-02-09 | — | — | US | claimed |
| US-5075289-A | Improved activity and therapeutic ratios | ABBOTT LABORATORIES (US) | 1991-12-24 | — | — | US | claimed |
| EP-0345627-A2 | 9-R-azacyclic erythromycin antibiotics | ABBOTT LABORATORIES (US) | 1989-12-13 | — | — | EP | claimed |